-RBI removes restriction on foreign investment in IDFC
-Delhi HC clears decks for potential deal by Fortis Healthcare to bring in new shareholders
-Glenmark gets tentative US FDA nod for Solifenacin Succinate tablets (used for treatment of overactive bladders)
-Tata Motors to issue non-convertible debentures worth Rs 500 crore
-Medicamen Biotech issues 3.06 lakh warrants to promoters and non promoters at Rs 543 per share
-Ramky Infra to sell non-civic waste unit: ET
-Coal India allows arms to reduce reserve price at auctions: ET
-Reliance Defence and Thales, to form JV for Rafale deal
-Delhi HC clears decks for potential deal by Fortis Healthcare to bring in new shareholders
-Glenmark gets tentative US FDA nod for Solifenacin Succinate tablets (used for treatment of overactive bladders)
-Tata Motors to issue non-convertible debentures worth Rs 500 crore
-Medicamen Biotech issues 3.06 lakh warrants to promoters and non promoters at Rs 543 per share
-Ramky Infra to sell non-civic waste unit: ET
-Coal India allows arms to reduce reserve price at auctions: ET
-Reliance Defence and Thales, to form JV for Rafale deal
No comments:
Post a Comment